Related Experiment Video
Updated: May 10, 2025

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Metabolic Effects of the Cancer Metastasis Modulator MEMO1
Marziyeh Ghanbarian1, Natalia Dolgova1, Frederick S Vizeacoumar2
1Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
The protein MEMO1 influences cancer cell metabolism by regulating the tricarboxylic acid (TCA) cycle. Its effect on TCA metabolites is dependent on iron availability, impacting cancer metastasis.
Area of Science:
- Biochemistry
- Cancer Biology
- Metabolic Regulation
Background:
- Cancer cells exhibit altered energy metabolism, with dysregulation of the tricarboxylic acid (TCA) cycle being a hallmark.
- MEMO1, a cancer metastasis modulator, interacts with iron and influences cellular iron homeostasis.
- Previous studies linked MEMO1 to mitochondrial respiration and TCA cycle genes in cancer cells.
Purpose of the Study:
- To investigate the role of MEMO1 in regulating TCA cycle metabolites in breast cancer cells.
- To determine the influence of iron availability on MEMO1's regulation of the TCA cycle.
Main Methods:
- Assessed the essentiality of TCA cycle enzymes using shRNA knockdown.
- Quantified TCA metabolites via liquid chromatography-tandem mass spectrometry (LC-MS/MS) in cells with varying MEMO1 expression (high, knockdown, knockout).
- Evaluated metabolite levels under iron-depleted, basal, and iron-supplemented conditions.
Main Results:
- Knockdown of ACO2 and OGDH inhibited cell proliferation, confirming TCA cycle's essentiality.
- Alpha-ketoglutarate and citrate levels increased in MEMO1 knockout cells, irrespective of iron.
- Fumarate, malate, and glutamate levels rose in MEMO1 knockout cells specifically under low iron conditions.
Conclusions:
- MEMO1 plays a significant role in regulating the TCA cycle within cancer cells.
- This regulation by MEMO1 is demonstrably iron-dependent.
- Understanding MEMO1's role in TCA cycle and iron metabolism may offer new therapeutic strategies for cancer.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...